| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Sichuan Hebang Biotechnology Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.05 |
| 52 Week High | CN¥2.62 |
| 52 Week Low | CN¥1.61 |
| Beta | 0.32 |
| 11 Month Change | -1.91% |
| 3 Month Change | 17.82% |
| 1 Year Change | -13.87% |
| 33 Year Change | -37.31% |
| 5 Year Change | 37.58% |
| Change since IPO | 19.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603077 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -2.8% | -1.8% | -1.2% |
| 1Y | -13.9% | -7.8% | 3.1% |
Return vs Industry: 603077 underperformed the CN Chemicals industry which returned -7.8% over the past year.
Return vs Market: 603077 underperformed the CN Market which returned 3.1% over the past year.
Price Volatility
| 603077 volatility | |
|---|---|
| 603077 Average Weekly Movement | 5.6% |
| Chemicals Industry Average Movement | 7.3% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in CN Market | 12.0% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603077 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603077's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 7,169 | Xiaoping Zeng | www.hebang.cn |
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products.
Sichuan Hebang Biotechnology Corporation Limited Fundamentals Summary
| 603077 fundamental statistics | |
|---|---|
| Market cap | CN¥16.45b |
| Earnings (TTM) | CN¥485.52m |
| Revenue (TTM) | CN¥9.20b |
33.9x
P/E Ratio1.8x
P/S RatioIs 603077 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603077 income statement (TTM) | |
|---|---|
| Revenue | CN¥9.20b |
| Cost of Revenue | CN¥8.02b |
| Gross Profit | CN¥1.18b |
| Other Expenses | CN¥696.34m |
| Earnings | CN¥485.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.06 |
| Gross Margin | 12.84% |
| Net Profit Margin | 5.28% |
| Debt/Equity Ratio | 17.6% |
How did 603077 perform over the long term?
See historical performance and comparison